Kasper Bonnesen - Publications

Non-steroidal anti-inflammatory drug use in patients with varying severity of coronary artery disease.

Journal: European journal of clinical pharmacology

Published: March 23, 2026

Empagliflozin Versus Dapagliflozin and Urogenital Adverse Events in Type 2 Diabetes: A Target Trial Emulation.

Journal: Diabetes, obesity & metabolism

Published: March 12, 2026

Regional Electronic Health Records in Denmark: Research Potential for Clinical Epidemiology.

Journal: Clinical epidemiology

Published: March 04, 2026

Compliance to direct oral anticoagulation therapy and clinical outcomes after catheter ablation for atrial fibrillation: a nationwide cohort study.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: February 23, 2026

Workforce Attachment After Patent Foramen Ovale Closure.

Journal: Structural heart : the journal of the Heart Team

Published: January 26, 2026

SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes.

Journal: JAMA internal medicine

Published: January 20, 2026

Empagliflozin vs Dapagliflozin in Heart Failure: a Target Trial Emulation.

Journal: Journal of cardiac failure

Published: August 21, 2025

Validity of Amyloidosis in the Danish National Patient Registry.

Journal: Clinical epidemiology

Published: June 12, 2025

Predicting heart failure mortality using the Danish Comorbidity Index for Acute Myocardial Infarction (DANCAMI).

Journal: Acta cardiologica

Published: May 15, 2025

Bleeding risk using non-steroidal anti-inflammatory drugs in anticoagulated patients with atrial fibrillation: a nationwide cohort study.

Journal: European heart journal. Quality of care & clinical outcomes

Published: May 13, 2025

Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".

Journal: Circulation

Published: April 28, 2025

Interaction between atrial fibrillation or flutter and the CHA2DS2-VASc score on the risk of ischemic stroke: A population-based cohort study.

Journal: International journal of cardiology

Published: April 12, 2025